Neuropathy Among the Diabetes Control and Complications Trial Cohort 8 Years After Trial Completion

2006347 citationsJournal Articlebronze Open Access

Authors

Catherine L. Martin

James W. Albers

Abstract

The benefits of 6.5 years of intensive therapy on neuropathy status extended for at least 8 years beyond the end of the DCCT, similar to the findings described for diabetic retinopathy and nephropathy.

Topics & Keywords

Pain Mechanisms and Treatments Botulinum Toxin and Related Neurological Disorders Neurological and metabolic disorders

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Diabetes Care

Volume 29, Issue 2, pp. 340-344

DOI: 10.2337/diacare.29.02.06.dc05-1549

Field-Weighted Citation Impact: 15.85